ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Amebiasis Treatment Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-31D992
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Amebiasis Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Global Amebiasis Treatment Market Insights, Forecast to 2030

Code: QYRE-Auto-31D992
Report
December 2024
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Dr. Reddy’s Laboratories
Mission Pharmacal
Aceto Corporation
Mylan Pharmaceuticals
Impax Laboratories
Pfizer Inc
Sanofi
Lupin Pharmaceuticals
Glenmark Pharmaceuticals
Sun Pharmaceutical
Heritage Pharmaceuticals

Amebiasis Treatment Market Size

The global Amebiasis Treatment market is projected to grow from US$ 928 million in 2024 to US$ 1323.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period.

Amebiasis Treatment Market

Amebiasis Treatment Market

Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica. Symptoms of this disease include loose stool, abdominal cramping, and stomach pain.
Market Analysis and Insights: Global Amebiasis Treatment Market
The amebiasis drugs market is driven by the high burden of amebiasis infections, caused by the parasite Entamoeba histolytica, especially in developing regions with poor sanitation and healthcare facilities. Amebiasis can lead to severe gastrointestinal symptoms and potentially life-threatening complications. The increasing prevalence and severity of the disease have contributed to the demand for effective drugs to treat and manage amebiasis. Additionally, advancements in medical research and drug development have led to the introduction of new and improved therapies for better patient outcomes. However, challenges include the need for early diagnosis and proper management to prevent complications, potential drug resistance, and limited access to healthcare in some regions. Overcoming these challenges through increased awareness, affordable treatment options, and improved healthcare infrastructure will be crucial for the sustained growth of the amebiasis drugs market.
Report Covers:
This report presents an overview of global market for Amebiasis Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Amebiasis Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Amebiasis Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Amebiasis Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Amebiasis Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Amebiasis Treatment revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Amebiasis Treatment Market Report

Report Metric Details
Report Name Amebiasis Treatment Market
Accounted market size in 2024 US$ 928 million
Forecasted market size in 2030 US$ 1323.9 million
CAGR 6.1
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
Segment by Application
  • Hospital
  • Pharmacy
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Dr. Reddy’s Laboratories, Mission Pharmacal, Aceto Corporation, Mylan Pharmaceuticals, Impax Laboratories, Pfizer, Sanofi, Lupin Pharmaceuticals, Glenmark Pharmaceuticals, Sun Pharmaceutical, Heritage Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Amebiasis Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Amebiasis Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Amebiasis Treatment revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Amebiasis Treatment Market growing?

Ans: The Amebiasis Treatment Market witnessing a CAGR of 6.1 during the forecast period 2025-2030.

What is the Amebiasis Treatment Market size in 2030?

Ans: The Amebiasis Treatment Market size in 2030 will be US$ 1323.9 million.

Who are the main players in the Amebiasis Treatment Market report?

Ans: The main players in the Amebiasis Treatment Market are Dr. Reddy’s Laboratories, Mission Pharmacal, Aceto Corporation, Mylan Pharmaceuticals, Impax Laboratories, Pfizer, Sanofi, Lupin Pharmaceuticals, Glenmark Pharmaceuticals, Sun Pharmaceutical, Heritage Pharmaceuticals

What are the Application segmentation covered in the Amebiasis Treatment Market report?

Ans: The Applications covered in the Amebiasis Treatment Market report are Hospital, Pharmacy

What are the Type segmentation covered in the Amebiasis Treatment Market report?

Ans: The Types covered in the Amebiasis Treatment Market report are Metronidazole, Paromomycin, Tinidazole, Other

Recommended Reports

Antiparasitic Treatments

Digestive & Intestinal

General Disease Treatment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Amebiasis Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Metronidazole
1.2.3 Paromomycin
1.2.4 Tinidazole
1.2.5 Other
1.3 Market by Application
1.3.1 Global Amebiasis Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Amebiasis Treatment Market Perspective (2019-2030)
2.2 Global Amebiasis Treatment Growth Trends by Region
2.2.1 Amebiasis Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Amebiasis Treatment Historic Market Size by Region (2019-2024)
2.2.3 Amebiasis Treatment Forecasted Market Size by Region (2025-2030)
2.3 Amebiasis Treatment Market Dynamics
2.3.1 Amebiasis Treatment Industry Trends
2.3.2 Amebiasis Treatment Market Drivers
2.3.3 Amebiasis Treatment Market Challenges
2.3.4 Amebiasis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Amebiasis Treatment by Players
3.1.1 Global Amebiasis Treatment Revenue by Players (2019-2024)
3.1.2 Global Amebiasis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Amebiasis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Amebiasis Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Amebiasis Treatment Market Concentration Ratio
3.4.1 Global Amebiasis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Amebiasis Treatment Revenue in 2023
3.5 Global Key Players of Amebiasis Treatment Head office and Area Served
3.6 Global Key Players of Amebiasis Treatment, Product and Application
3.7 Global Key Players of Amebiasis Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Amebiasis Treatment Breakdown Data by Type
4.1 Global Amebiasis Treatment Historic Market Size by Type (2019-2024)
4.2 Global Amebiasis Treatment Forecasted Market Size by Type (2025-2030)
5 Amebiasis Treatment Breakdown Data by Application
5.1 Global Amebiasis Treatment Historic Market Size by Application (2019-2024)
5.2 Global Amebiasis Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Amebiasis Treatment Market Size (2019-2030)
6.2 North America Amebiasis Treatment Market Size by Type
6.2.1 North America Amebiasis Treatment Market Size by Type (2019-2024)
6.2.2 North America Amebiasis Treatment Market Size by Type (2025-2030)
6.2.3 North America Amebiasis Treatment Market Share by Type (2019-2030)
6.3 North America Amebiasis Treatment Market Size by Application
6.3.1 North America Amebiasis Treatment Market Size by Application (2019-2024)
6.3.2 North America Amebiasis Treatment Market Size by Application (2025-2030)
6.3.3 North America Amebiasis Treatment Market Share by Application (2019-2030)
6.4 North America Amebiasis Treatment Market Size by Country
6.4.1 North America Amebiasis Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Amebiasis Treatment Market Size by Country (2019-2024)
6.4.3 North America Amebiasis Treatment Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Amebiasis Treatment Market Size (2019-2030)
7.2 Europe Amebiasis Treatment Market Size by Type
7.2.1 Europe Amebiasis Treatment Market Size by Type (2019-2024)
7.2.2 Europe Amebiasis Treatment Market Size by Type (2025-2030)
7.2.3 Europe Amebiasis Treatment Market Share by Type (2019-2030)
7.3 Europe Amebiasis Treatment Market Size by Application
7.3.1 Europe Amebiasis Treatment Market Size by Application (2019-2024)
7.3.2 Europe Amebiasis Treatment Market Size by Application (2025-2030)
7.3.3 Europe Amebiasis Treatment Market Share by Application (2019-2030)
7.4 Europe Amebiasis Treatment Market Size by Country
7.4.1 Europe Amebiasis Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Amebiasis Treatment Market Size by Country (2019-2024)
7.4.3 Europe Amebiasis Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Amebiasis Treatment Market Size (2019-2030)
8.2 China Amebiasis Treatment Market Size by Type
8.2.1 China Amebiasis Treatment Market Size by Type (2019-2024)
8.2.2 China Amebiasis Treatment Market Size by Type (2025-2030)
8.2.3 China Amebiasis Treatment Market Share by Type (2019-2030)
8.3 China Amebiasis Treatment Market Size by Application
8.3.1 China Amebiasis Treatment Market Size by Application (2019-2024)
8.3.2 China Amebiasis Treatment Market Size by Application (2025-2030)
8.3.3 China Amebiasis Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Amebiasis Treatment Market Size (2019-2030)
9.2 Asia Amebiasis Treatment Market Size by Type
9.2.1 Asia Amebiasis Treatment Market Size by Type (2019-2024)
9.2.2 Asia Amebiasis Treatment Market Size by Type (2025-2030)
9.2.3 Asia Amebiasis Treatment Market Share by Type (2019-2030)
9.3 Asia Amebiasis Treatment Market Size by Application
9.3.1 Asia Amebiasis Treatment Market Size by Application (2019-2024)
9.3.2 Asia Amebiasis Treatment Market Size by Application (2025-2030)
9.3.3 Asia Amebiasis Treatment Market Share by Application (2019-2030)
9.4 Asia Amebiasis Treatment Market Size by Region
9.4.1 Asia Amebiasis Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Amebiasis Treatment Market Size by Region (2019-2024)
9.4.3 Asia Amebiasis Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Amebiasis Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Amebiasis Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Amebiasis Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Amebiasis Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Amebiasis Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Amebiasis Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Amebiasis Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Amebiasis Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Amebiasis Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Amebiasis Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Amebiasis Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Amebiasis Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Amebiasis Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Dr. Reddy’s Laboratories
11.1.1 Dr. Reddy’s Laboratories Company Details
11.1.2 Dr. Reddy’s Laboratories Business Overview
11.1.3 Dr. Reddy’s Laboratories Amebiasis Treatment Introduction
11.1.4 Dr. Reddy’s Laboratories Revenue in Amebiasis Treatment Business (2019-2024)
11.1.5 Dr. Reddy’s Laboratories Recent Developments
11.2 Mission Pharmacal
11.2.1 Mission Pharmacal Company Details
11.2.2 Mission Pharmacal Business Overview
11.2.3 Mission Pharmacal Amebiasis Treatment Introduction
11.2.4 Mission Pharmacal Revenue in Amebiasis Treatment Business (2019-2024)
11.2.5 Mission Pharmacal Recent Developments
11.3 Aceto Corporation
11.3.1 Aceto Corporation Company Details
11.3.2 Aceto Corporation Business Overview
11.3.3 Aceto Corporation Amebiasis Treatment Introduction
11.3.4 Aceto Corporation Revenue in Amebiasis Treatment Business (2019-2024)
11.3.5 Aceto Corporation Recent Developments
11.4 Mylan Pharmaceuticals
11.4.1 Mylan Pharmaceuticals Company Details
11.4.2 Mylan Pharmaceuticals Business Overview
11.4.3 Mylan Pharmaceuticals Amebiasis Treatment Introduction
11.4.4 Mylan Pharmaceuticals Revenue in Amebiasis Treatment Business (2019-2024)
11.4.5 Mylan Pharmaceuticals Recent Developments
11.5 Impax Laboratories
11.5.1 Impax Laboratories Company Details
11.5.2 Impax Laboratories Business Overview
11.5.3 Impax Laboratories Amebiasis Treatment Introduction
11.5.4 Impax Laboratories Revenue in Amebiasis Treatment Business (2019-2024)
11.5.5 Impax Laboratories Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Amebiasis Treatment Introduction
11.6.4 Pfizer Revenue in Amebiasis Treatment Business (2019-2024)
11.6.5 Pfizer Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Amebiasis Treatment Introduction
11.7.4 Sanofi Revenue in Amebiasis Treatment Business (2019-2024)
11.7.5 Sanofi Recent Developments
11.8 Lupin Pharmaceuticals
11.8.1 Lupin Pharmaceuticals Company Details
11.8.2 Lupin Pharmaceuticals Business Overview
11.8.3 Lupin Pharmaceuticals Amebiasis Treatment Introduction
11.8.4 Lupin Pharmaceuticals Revenue in Amebiasis Treatment Business (2019-2024)
11.8.5 Lupin Pharmaceuticals Recent Developments
11.9 Glenmark Pharmaceuticals
11.9.1 Glenmark Pharmaceuticals Company Details
11.9.2 Glenmark Pharmaceuticals Business Overview
11.9.3 Glenmark Pharmaceuticals Amebiasis Treatment Introduction
11.9.4 Glenmark Pharmaceuticals Revenue in Amebiasis Treatment Business (2019-2024)
11.9.5 Glenmark Pharmaceuticals Recent Developments
11.10 Sun Pharmaceutical
11.10.1 Sun Pharmaceutical Company Details
11.10.2 Sun Pharmaceutical Business Overview
11.10.3 Sun Pharmaceutical Amebiasis Treatment Introduction
11.10.4 Sun Pharmaceutical Revenue in Amebiasis Treatment Business (2019-2024)
11.10.5 Sun Pharmaceutical Recent Developments
11.11 Heritage Pharmaceuticals
11.11.1 Heritage Pharmaceuticals Company Details
11.11.2 Heritage Pharmaceuticals Business Overview
11.11.3 Heritage Pharmaceuticals Amebiasis Treatment Introduction
11.11.4 Heritage Pharmaceuticals Revenue in Amebiasis Treatment Business (2019-2024)
11.11.5 Heritage Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Dr. Reddy’s Laboratories
Mission Pharmacal
Aceto Corporation
Mylan Pharmaceuticals
Impax Laboratories
Pfizer Inc
Sanofi
Lupin Pharmaceuticals
Glenmark Pharmaceuticals
Sun Pharmaceutical
Heritage Pharmaceuticals
List of Tables
    Table 1. Global Amebiasis Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Metronidazole
    Table 3. Key Players of Paromomycin
    Table 4. Key Players of Tinidazole
    Table 5. Key Players of Other
    Table 6. Global Amebiasis Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Amebiasis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Amebiasis Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Amebiasis Treatment Market Share by Region (2019-2024)
    Table 10. Global Amebiasis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Amebiasis Treatment Market Share by Region (2025-2030)
    Table 12. Amebiasis Treatment Market Trends
    Table 13. Amebiasis Treatment Market Drivers
    Table 14. Amebiasis Treatment Market Challenges
    Table 15. Amebiasis Treatment Market Restraints
    Table 16. Global Amebiasis Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Amebiasis Treatment Revenue Share by Players (2019-2024)
    Table 18. Global Top Amebiasis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amebiasis Treatment as of 2023)
    Table 19. Global Amebiasis Treatment Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Amebiasis Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Amebiasis Treatment, Headquarters and Area Served
    Table 22. Global Key Players of Amebiasis Treatment, Product and Application
    Table 23. Global Key Players of Amebiasis Treatment, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Amebiasis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Amebiasis Treatment Revenue Market Share by Type (2019-2024)
    Table 27. Global Amebiasis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Amebiasis Treatment Revenue Market Share by Type (2025-2030)
    Table 29. Global Amebiasis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Amebiasis Treatment Revenue Share by Application (2019-2024)
    Table 31. Global Amebiasis Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Amebiasis Treatment Revenue Share by Application (2025-2030)
    Table 33. North America Amebiasis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Amebiasis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Amebiasis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Amebiasis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Amebiasis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Amebiasis Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Amebiasis Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Amebiasis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Amebiasis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Amebiasis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Amebiasis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Amebiasis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Amebiasis Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Amebiasis Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Amebiasis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Amebiasis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Amebiasis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Amebiasis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Amebiasis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Amebiasis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Amebiasis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Amebiasis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Amebiasis Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Amebiasis Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Amebiasis Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Amebiasis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Amebiasis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Amebiasis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Amebiasis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Amebiasis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Amebiasis Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Amebiasis Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Dr. Reddy’s Laboratories Company Details
    Table 66. Dr. Reddy’s Laboratories Business Overview
    Table 67. Dr. Reddy’s Laboratories Amebiasis Treatment Product
    Table 68. Dr. Reddy’s Laboratories Revenue in Amebiasis Treatment Business (2019-2024) & (US$ Million)
    Table 69. Dr. Reddy’s Laboratories Recent Developments
    Table 70. Mission Pharmacal Company Details
    Table 71. Mission Pharmacal Business Overview
    Table 72. Mission Pharmacal Amebiasis Treatment Product
    Table 73. Mission Pharmacal Revenue in Amebiasis Treatment Business (2019-2024) & (US$ Million)
    Table 74. Mission Pharmacal Recent Developments
    Table 75. Aceto Corporation Company Details
    Table 76. Aceto Corporation Business Overview
    Table 77. Aceto Corporation Amebiasis Treatment Product
    Table 78. Aceto Corporation Revenue in Amebiasis Treatment Business (2019-2024) & (US$ Million)
    Table 79. Aceto Corporation Recent Developments
    Table 80. Mylan Pharmaceuticals Company Details
    Table 81. Mylan Pharmaceuticals Business Overview
    Table 82. Mylan Pharmaceuticals Amebiasis Treatment Product
    Table 83. Mylan Pharmaceuticals Revenue in Amebiasis Treatment Business (2019-2024) & (US$ Million)
    Table 84. Mylan Pharmaceuticals Recent Developments
    Table 85. Impax Laboratories Company Details
    Table 86. Impax Laboratories Business Overview
    Table 87. Impax Laboratories Amebiasis Treatment Product
    Table 88. Impax Laboratories Revenue in Amebiasis Treatment Business (2019-2024) & (US$ Million)
    Table 89. Impax Laboratories Recent Developments
    Table 90. Pfizer Company Details
    Table 91. Pfizer Business Overview
    Table 92. Pfizer Amebiasis Treatment Product
    Table 93. Pfizer Revenue in Amebiasis Treatment Business (2019-2024) & (US$ Million)
    Table 94. Pfizer Recent Developments
    Table 95. Sanofi Company Details
    Table 96. Sanofi Business Overview
    Table 97. Sanofi Amebiasis Treatment Product
    Table 98. Sanofi Revenue in Amebiasis Treatment Business (2019-2024) & (US$ Million)
    Table 99. Sanofi Recent Developments
    Table 100. Lupin Pharmaceuticals Company Details
    Table 101. Lupin Pharmaceuticals Business Overview
    Table 102. Lupin Pharmaceuticals Amebiasis Treatment Product
    Table 103. Lupin Pharmaceuticals Revenue in Amebiasis Treatment Business (2019-2024) & (US$ Million)
    Table 104. Lupin Pharmaceuticals Recent Developments
    Table 105. Glenmark Pharmaceuticals Company Details
    Table 106. Glenmark Pharmaceuticals Business Overview
    Table 107. Glenmark Pharmaceuticals Amebiasis Treatment Product
    Table 108. Glenmark Pharmaceuticals Revenue in Amebiasis Treatment Business (2019-2024) & (US$ Million)
    Table 109. Glenmark Pharmaceuticals Recent Developments
    Table 110. Sun Pharmaceutical Company Details
    Table 111. Sun Pharmaceutical Business Overview
    Table 112. Sun Pharmaceutical Amebiasis Treatment Product
    Table 113. Sun Pharmaceutical Revenue in Amebiasis Treatment Business (2019-2024) & (US$ Million)
    Table 114. Sun Pharmaceutical Recent Developments
    Table 115. Heritage Pharmaceuticals Company Details
    Table 116. Heritage Pharmaceuticals Business Overview
    Table 117. Heritage Pharmaceuticals Amebiasis Treatment Product
    Table 118. Heritage Pharmaceuticals Revenue in Amebiasis Treatment Business (2019-2024) & (US$ Million)
    Table 119. Heritage Pharmaceuticals Recent Developments
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Amebiasis Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Amebiasis Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Metronidazole Features
    Figure 4. Paromomycin Features
    Figure 5. Tinidazole Features
    Figure 6. Other Features
    Figure 7. Global Amebiasis Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Amebiasis Treatment Market Share by Application: 2023 VS 2030
    Figure 9. Hospital Case Studies
    Figure 10. Pharmacy Case Studies
    Figure 11. Amebiasis Treatment Report Years Considered
    Figure 12. Global Amebiasis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Amebiasis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Amebiasis Treatment Market Share by Region: 2023 VS 2030
    Figure 15. Global Amebiasis Treatment Market Share by Players in 2023
    Figure 16. Global Top Amebiasis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amebiasis Treatment as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Amebiasis Treatment Revenue in 2023
    Figure 18. North America Amebiasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Amebiasis Treatment Market Share by Type (2019-2030)
    Figure 20. North America Amebiasis Treatment Market Share by Application (2019-2030)
    Figure 21. North America Amebiasis Treatment Market Share by Country (2019-2030)
    Figure 22. United States Amebiasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Amebiasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Amebiasis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Amebiasis Treatment Market Share by Type (2019-2030)
    Figure 26. Europe Amebiasis Treatment Market Share by Application (2019-2030)
    Figure 27. Europe Amebiasis Treatment Market Share by Country (2019-2030)
    Figure 28. Germany Amebiasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Amebiasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Amebiasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Amebiasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Amebiasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Amebiasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Amebiasis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Amebiasis Treatment Market Share by Type (2019-2030)
    Figure 36. China Amebiasis Treatment Market Share by Application (2019-2030)
    Figure 37. Asia Amebiasis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Amebiasis Treatment Market Share by Type (2019-2030)
    Figure 39. Asia Amebiasis Treatment Market Share by Application (2019-2030)
    Figure 40. Asia Amebiasis Treatment Market Share by Region (2019-2030)
    Figure 41. Japan Amebiasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Amebiasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Amebiasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Amebiasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Amebiasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Amebiasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Amebiasis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Amebiasis Treatment Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Amebiasis Treatment Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Amebiasis Treatment Market Share by Country (2019-2030)
    Figure 51. Brazil Amebiasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Amebiasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Amebiasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Amebiasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Amebiasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Amebiasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Dr. Reddy’s Laboratories Revenue Growth Rate in Amebiasis Treatment Business (2019-2024)
    Figure 58. Mission Pharmacal Revenue Growth Rate in Amebiasis Treatment Business (2019-2024)
    Figure 59. Aceto Corporation Revenue Growth Rate in Amebiasis Treatment Business (2019-2024)
    Figure 60. Mylan Pharmaceuticals Revenue Growth Rate in Amebiasis Treatment Business (2019-2024)
    Figure 61. Impax Laboratories Revenue Growth Rate in Amebiasis Treatment Business (2019-2024)
    Figure 62. Pfizer Revenue Growth Rate in Amebiasis Treatment Business (2019-2024)
    Figure 63. Sanofi Revenue Growth Rate in Amebiasis Treatment Business (2019-2024)
    Figure 64. Lupin Pharmaceuticals Revenue Growth Rate in Amebiasis Treatment Business (2019-2024)
    Figure 65. Glenmark Pharmaceuticals Revenue Growth Rate in Amebiasis Treatment Business (2019-2024)
    Figure 66. Sun Pharmaceutical Revenue Growth Rate in Amebiasis Treatment Business (2019-2024)
    Figure 67. Heritage Pharmaceuticals Revenue Growth Rate in Amebiasis Treatment Business (2019-2024)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Amebiasis Market Insights Forecast to 2030
Global Amebiasis Therapeutics Market Insights Forecast to 2030
Global Amebiasis Drugs Market Insights Forecast to 2030
Global Parasitic Diseases Therapeutic Market Insights Forecast to 2030
Intestinal Ascariasis Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Leishmaniasis Treatment Market Insights Forecast to 2030
Enteric Parasite Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Digestive Drugs Market Insights Forecast to 2030
Global Cryptococcosis Treatment Market Insights Forecast to 2030
Global Anemia Treatment Drugs Market Insights Forecast to 2030
Global Ectoparasiticides Market Insights Forecast to 2030
Global Liver Fluke Treatment Market Insights Forecast to 2030
Gastrointestinal Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Waste Treatment Market Insights Forecast to 2030
Global Necrotic Enteritis Drug Market Insights Forecast to 2030
Global Infectious Disease Drugs Market Insights Forecast to 2030
Global Coccidiosis Treatment Market Research Report 2024
Global Healthcare Bowel Management Systems Market Insights Forecast to 2030
Global Angioedema Treatment Market Insights Forecast to 2030
Global Irritable Bowel Syndrome IBS Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions